Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Segment Analysis By Brand: Ozempics Diabetes Franchise Anchors Revenue While Wegovy Captures Obesity Growth Ozempic held a 65.31% brand share in 2025, underpinned by its 2017 launch and subsequent inclusion in cardiometabolic guidelines following the SUSTAIN-6 study, which showed a 26% reduction in cardiovascular events
Honoured as Dermatologist of the Year 2026 by Financial Express, Dermatologist of the Year 2023 by The Economic Times and Jury Member at Vogue Beauty & Wellness Honours 2026
Vitamin B12 deficiency in long-term metformin treated type 2 diabetic patients: prevalence and risk factors in a Tunisian population
By modulating dopamine, these medicines may reduce cravings and impulsive behaviours explaining why many patients feel more in control, not just around food but in everyday life
US$ 21.95
US$ 20.17
US$ 21.23
US$ 20.02
US$ 26.24
US$ 28.16
